drugset / Trial / NCT03472521

Prevention of Persistent Opioid Use in Mothers

NCT03472521

Phase 4 Completed 78 enrolled Stanford University
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Our previous work has identified the group of women at risk for prolonged pain, opioid use and poor functional recovery after childbirth. The optimal intervention to mitigate this risk is unknown. We propose to test an analgesic adjutant that is commonly used for post-operative pain compared to placebo to improve post-partum recovery.

Timeline

Start
2018-09-17
Primary completion
2020-07-02
Completion
2021-04-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Gabapentin Small molecule 300 mg